Our Assessment Board (FDAP)

Katherine Jenkins

FDAP Assessment Board member Read more

Daniel Frings

FDAP Assessment Board member Read more

Gillian Ward

Chair, FDAP Assessment Board Read more

James Binnie

FDAP Assessment Board member Read more

Cathy MacGregor

FDAP Assessment Board member Read more

Rafaella (Marghe) Milani

FDAP Assessment Board member Read more

Tim Leighton

FDAP Assessment Board member Read more

Latest

SMMGP Medicinal Cannabis Sponsored Clinical Update

This sponsored clinical update focuses on the emerging evidence base for medicinal cannabis for a range of indications. It has been made possible by an unrestricted education grant from Althea MMJ UK Ltd., a licensed producer, supplier and exporter of pharmaceutical grade medicinal cannabis.
Independent review of drugs: call for evidence, part 2

An independent review into the use and supply of illicit drugs, seeking views on how to reduce harm to individuals and society. This consultation closes at 11:59pm on 6 August 2020
May 2020 Newsletter

Latest news from SMMGP and FDAP
Free Virtual Annual Conference 2020: What does good look like during and after COVID-19?

for the NHS Substance Misuse Provider Forum.

Most read

FDAP Individual membership

Federation of Drug and Alcohol Practitioners (FDAP) - the professional register for individuals working in the addictions field.
SMMGP Premium membership

Become an SMMGP Premium Member for access to quality CPD. Individual FDAP members have free access to our Premium Membership.
Free resources

Free learning available on our website, click for more information.
FDAP Practitioner Directory

Federation of Drug & Alcohol Practitioners (FDAP) - directory of members.
Addiction services change lives

We support and educate the addictions workforce
Jobs

Look for jobs within the sector.
FDAP Drug and Alcohol Professional Certificate
Clinical Guidelines (2017) - "Orange Book"

Drug Misuse and Dependence - UK Guidelines on Clinical Management. 2017 edition.
Free recorded webinar: Long-acting buprenorphine in criminal justice settings: implications for services
Free Clinical Update: Special Edition

This clinical update focuses on Buvidal® (CAM2038), the new prolonged-release subcutaneous buprenorphine injection for opioid use disorder.

FDAP Individual membership

Federation of Drug and Alcohol Practitioners (FDAP) - the professional register for individuals working in the addictions field. Read more

SMMGP Premium membership

Become an SMMGP Premium Member for access to quality CPD. Individual FDAP members have free access to our Premium Membership. Read more